MapLight Therapeutics, Inc. (MPLT) Institutional Shareholders

MapLight Therapeutics, Inc. (MPLT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $942.10M in MPLT holdings during the latest filing period.

Novo Holdings A/S is currently the largest disclosed institutional shareholder of MPLT tracked by InsiderSet, reporting ownership valued at approximately $132.13M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $40.26M, representing an estimated loss of -69.53% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 68% of the total disclosed MPLT value among the investors covered in this analysis. Major shareholders include Novo Holdings A/S, Fcpm Iii Services B.V., T. Rowe Price Investment Management, Inc., and several other long-term asset managers with concentrated positions in MapLight Therapeutics, Inc. (MPLT).

This page ranks the largest institutional MPLT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

105

Total Reported Value

$942.10M

Largest Holder

Novo Holdings A/S

Largest Position

$132.13M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

124

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Novo Holdings A/S7.67%3,686,622$132,128,532$40,257,912-$91,870,620-69.53%
Fcpm Iii Services B.V.15.41%3,226,400$115,634,176$35,232,288-$80,401,888-69.53%
T. Rowe Price Investment Management, Inc.0.07%2,781,728$99,698,000$30,376,470-$69,321,530-69.53%
Goldman Sachs Group Inc0.01%1,948,312$69,827,502$21,275,567-$48,551,935-69.53%
Price T Rowe Associates Inc0.01%1,422,935$50,999,000$15,538,450-$35,460,550-69.53%
Blackrock, Inc.0.00%1,025,134$36,740,802$11,194,463-$25,546,339-69.53%
Nan Fung Group Holdings Ltd26.47%971,253$34,809,708$10,606,083-$24,203,625-69.53%
5Am Venture Management, Llc11.83%950,011$34,048,394$10,374,120-$23,674,274-69.53%
Sanofi6.12%912,041$32,687,549$9,959,488-$22,728,061-69.53%
State Street Corp0.00%852,150$30,541,056$9,305,478-$21,235,578-69.53%
Fmr Llc0.00%823,556$29,516,247$8,993,232-$20,523,015-69.53%
Vanguard Capital Management Llc0.00%784,150$28,103,936$8,562,918-$19,541,018-69.53%
Blue Owl Capital Holdings Lp3.98%729,929$26,160,655$7,970,825-$18,189,830-69.53%
Paradigm Biocapital Advisors Lp0.46%685,852$24,580,936$7,489,504-$17,091,432-69.53%
Pivotal Bioventure Partners Investment Advisor Llc7.12%611,446$21,914,225$6,676,990-$15,237,235-69.53%
Velan Capital Investment Management Lp10.82%492,893$17,665,285$5,382,392-$12,282,893-69.53%
Siren, L.L.C.0.33%450,000$16,128,000$4,914,000-$11,214,000-69.53%
Capital World Investors0.00%415,730$14,899,763$4,539,772-$10,359,991-69.53%
Geode Capital Management, Llc0.00%402,051$14,414,363$4,390,397-$10,023,966-69.54%
Baker Bros. Advisors Lp0.07%364,705$13,071,027$3,982,579-$9,088,448-69.53%
Dafna Capital Management Llc1.17%171,006$6,128,855$1,867,386-$4,261,469-69.53%
Bnp Paribas Asset Management Holding S.A.0.01%170,862$6,123,694$1,865,813-$4,257,881-69.53%
Freestone Grove Partners Lp0.04%168,912$6,053,806$1,844,519-$4,209,287-69.53%
Charles Schwab Investment Management Inc0.00%136,818$4,903,557$1,494,053-$3,409,504-69.53%
Millennium Management Llc0.00%128,841$4,617,661$1,406,944-$3,210,717-69.53%
Superstring Capital Management Lp2.84%125,432$4,495,483$1,369,717-$3,125,766-69.53%
Vanguard Fiduciary Trust Co0.00%123,135$4,413,158$1,344,634-$3,068,524-69.53%
Ubs Group Ag0.00%122,028$4,373,484$1,332,546-$3,040,938-69.53%
Northern Trust Corp0.00%116,652$4,180,808$1,273,840-$2,906,968-69.53%
Stempoint Capital Lp0.66%106,906$3,831,511$1,167,414-$2,664,097-69.53%
Seven Grand Managers, Llc0.14%100,000$3,584,000$1,092,000-$2,492,000-69.53%
Vanguard Portfolio Management Llc0.00%96,761$3,467,914$1,056,630-$2,411,284-69.53%
Lazard Asset Management Llc0.00%80,082$2,870,139$874,495-$1,995,644-69.53%
Boxer Capital Management, Llc0.20%75,000$2,688,000$819,000-$1,869,000-69.53%
Burkehill Global Management, Lp0.10%75,000$2,688,000$819,000-$1,869,000-69.53%
Bnp Paribas Financial Markets0.00%70,484$2,526,147$769,685-$1,756,462-69.53%
Trexquant Investment Lp0.01%63,792$2,286,305$696,609-$1,589,696-69.53%
Td Asset Management Inc0.00%54,526$1,954,212$595,424-$1,358,788-69.53%
Bank Of America Corp0.00%54,464$1,951,990$594,747-$1,357,243-69.53%
Hrt Financial Lp0.00%51,983$1,863,000$567,654-$1,295,346-69.53%
Wellington Management Group Llp0.00%51,917$1,860,705$566,934-$1,293,771-69.53%
Jain Global Llc0.02%45,551$1,632,548$497,417-$1,135,131-69.53%
Morgan Stanley0.00%38,304$1,372,815$418,280-$954,535-69.53%
Bridgeway Capital Management, Llc0.02%35,000$1,254,400$382,200-$872,200-69.53%
Weiss Asset Management Lp0.01%33,094$1,186,089$361,386-$824,703-69.53%
Janus Henderson Group Plc0.00%54,752$1,113,108$597,892-$515,216-46.29%
Bank Of New York Mellon Corp0.00%30,410$1,089,894$332,077-$757,817-69.53%
Adar1 Capital Management, Llc0.04%26,497$949,652$289,347-$660,305-69.53%
Citadel Advisors Llc0.00%25,751$922,916$281,201-$641,715-69.53%
Jump Financial, Llc0.01%25,222$903,956$275,424-$628,532-69.53%
Showing 50 of 105

Frequently asked questions about MPLT

  • Who owns the most MPLT stock?

    The largest holders of MPLT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for MapLight Therapeutics, Inc. (MPLT).

  • Is MPLT widely held by superinvestors?

    Many widely followed stocks like MPLT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly MPLT is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.